Cannabis Bioscience International Holdings (CBIH) Income from Continuing Operations (2022 - 2026)
Cannabis Bioscience International Holdings' Income from Continuing Operations history spans 5 years, with the latest figure at 104035.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 31.42% to 104035.0 in Q1 2026 year-over-year; TTM through Feb 2026 was 532943.0, a 76.64% decrease, with the full-year FY2025 number at 557627.0, down 12.17% from a year prior.
- Income from Continuing Operations hit 104035.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from 99107.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for CBIH hit a ceiling of 18270.0 in Q2 2024 and a floor of 324655.0 in Q1 2023.
- Historically, Income from Continuing Operations has averaged 152913.5 across 5 years, with a median of 127871.0 in 2025.
- Biggest five-year swings in Income from Continuing Operations: skyrocketed 106.62% in 2024 and later plummeted 1400.76% in 2025.
- Tracing CBIH's Income from Continuing Operations over 5 years: stood at 219886.0 in 2022, then surged by 57.02% to 94512.0 in 2023, then rose by 27.7% to 68328.0 in 2024, then crashed by 45.05% to 99107.0 in 2025, then dropped by 4.97% to 104035.0 in 2026.
- Business Quant data shows Income from Continuing Operations for CBIH at 104035.0 in Q1 2026, 99107.0 in Q4 2025, and 92152.0 in Q3 2025.